{"id":91544,"date":"2024-03-28T14:13:00","date_gmt":"2024-03-28T17:13:00","guid":{"rendered":""},"modified":"2024-03-28T14:13:00","modified_gmt":"2024-03-28T17:13:00","slug":"a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2","status":"publish","type":"post","link":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/","title":{"rendered":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos"},"content":{"rendered":"<p><b>PR NEWSWIRE<\/b><\/p>\n<div class=\"xn-content\">\n<span class=\"legendSpanClass\"><span class=\"xn-location\">MONTREAL<\/span>, CANAD\u00c1<\/span>, <span class=\"legendSpanClass\">28 de mar\u00e7o de 2024<\/span> \/PRNewswire\/ &#8212; A Knight Therapeutics Inc. (TSX: GUD) (A &#8220;Knight&#8221; ou &#8220;a Empresa&#8221;) tem o prazer de anunciar que ser\u00e1 reconhecida na quinta lista anual da revista The Globe and Mail&#8217;s 2024 Report on Business Women Lead Here. Esse referencial editorial anual identifica as empresas canadenses de alto n\u00edvel com a maior diversidade de g\u00eanero entre os executivos.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2959\">\n<a href=\"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.html\" target=\"_blank\" rel=\"nofollow noopener\"><img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\" title=\"(CNW Group\/Knight Therapeutics)\" alt=\"(CNW Group\/Knight Therapeutics)\" \/><\/a><\/p>\n<\/div>\n<p>O referencial Women Lead Here foi estabelecido em 2020 pela revista Report on Business e aplica uma metodologia de pesquisa pr\u00f3pria para fornecer uma vis\u00e3o geral das maiores corpora\u00e7\u00f5es canadenses com o mais alto grau de diversidade de g\u00eanero entre os executivos. As empresas classificadas fizeram progressos tang\u00edveis e organizacionais relacionados \u00e0 paridade de g\u00eanero dos executivos.<\/p>\n<p>&#8220;O reconhecimento das conquistas das empresas que enfrentam com efic\u00e1cia os desafios da paridade de g\u00eanero dos executivos representa um avan\u00e7o fundamental&#8221;, afirma <span class=\"xn-person\">Dawn Calleja<\/span>, editora da revista Report on Business. &#8220;Embora possa sempre haver mais a ser feito, as empresas aqui apresentadas servem como catalisadores para o Canad\u00e1 corporativo, inspirando-as a progredir em dire\u00e7\u00e3o \u00e0 paridade de g\u00eanero e, por sua vez, cultivar empresas excepcionais.&#8221;<\/p>\n<p>&#8220;Temos a honra de ver mais uma vez a Knight Therapeutics Inc. inclu\u00edda na publica\u00e7\u00e3o Globe and Mail&#8217;s Report on <span class=\"xn-location\">Canada&#8217;s<\/span> Women Lead Here como uma das empresas l\u00edderes em diversifica\u00e7\u00e3o de g\u00eanero entre executivos no Canad\u00e1 corporativo e no setor de especialidades farmac\u00eauticas&#8221;, disse Samira Sakhia, Presidente e Diretora Executiva da Knight. &#8220;Nosso compromisso com a diversidade e a inclus\u00e3o est\u00e1 enraizado em nossos valores fundamentais e o defendemos ativamente todos os dias, tanto em nossa empresa quanto em nosso servi\u00e7o dedicado aos pacientes&#8221;.<\/p>\n<p>Para a classifica\u00e7\u00e3o de 2024, a Report on Business realizou uma an\u00e1lise jornal\u00edstica de aproximadamente 500 grandes empresas canadenses de capital aberto com base na receita, avaliando a propor\u00e7\u00e3o de executivos que se identificam como mulheres em rela\u00e7\u00e3o aos que se identificam como homens nos tr\u00eas n\u00edveis mais altos de lideran\u00e7a executiva. Os dados obtidos foram aplicados a uma f\u00f3rmula ponderada que tamb\u00e9m levou em conta o desempenho da empresa, a diversidade e a mudan\u00e7a de ano para ano.<\/p>\n<p>No total, 97 empresas receberam o selo 2024 Women Lead Here, com uma m\u00e9dia combinada de 45% dos cargos executivos ocupados por pessoas do sexo feminino.<\/p>\n<p>A lista 2024 Women Lead Here ser\u00e1 publicada na edi\u00e7\u00e3o de abril de 2024 da revista Report on Business, distribu\u00edda com The Globe and Mail em 30 de mar\u00e7o de 2024 e on-line em <b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=3264083668&amp;u=https%3A%2F%2Fwww.theglobeandmail.com%2Fbusiness%2Frob-magazine%2Farticle-women-lead-here-corporate-canada-female-leadership-ranked%2F&amp;a=tgam.ca%2FWomenLeadHere\" target=\"_blank\" rel=\"nofollow noopener\">tgam.ca\/WomenLeadHere<\/a><\/b><\/p>\n<p><b>Sobre <\/b>&laquo;<b>The Globe and Mail&raquo;<\/b><\/p>\n<p>&laquo;The Globe and Mail&raquo; \u00e9 a principal empresa de m\u00eddia de not\u00edcias do Canad\u00e1, liderando a discuss\u00e3o nacional e causando mudan\u00e7as pol\u00edticas por meio de um jornalismo corajoso e independente desde 1844. Com nossa cobertura premiada de neg\u00f3cios, pol\u00edtica e assuntos nacionais, o jornal &laquo;The Globe and Mail&raquo; atinge 6,2 milh\u00f5es de leitores todas as semanas em nossos formatos impresso ou digital, e a revista &laquo;Report on Business&raquo; atinge 2,9 milh\u00f5es de leitores impressos e digitais a cada edi\u00e7\u00e3o. Nosso investimento em ci\u00eancia de dados inovadora significa que, \u00e0 medida que o mundo continua a mudar, o mesmo acontece com o The Globe. O &laquo;The Globe and Mail&raquo; \u00e9 propriedade da <span class=\"xn-location\">Woodbridge<\/span>, o bra\u00e7o de investimentos da fam\u00edlia Thomson.<\/p>\n<p><b>Sobre a Knight Therapeutics Inc. <\/b><\/p>\n<p>A Knight Therapeutics Inc., com sede em <span class=\"xn-location\">Montreal<\/span>, Canad\u00e1, \u00e9 uma empresa farmac\u00eautica especializada com foco na aquisi\u00e7\u00e3o ou licenciamento e comercializa\u00e7\u00e3o de produtos farmac\u00eauticos para o Canad\u00e1 e a Am\u00e9rica Latina. As subsidi\u00e1rias latino-americanas da Knight operam sob os nomes United Medical, Biotoscana Farma e Laboratorio LKM. As a\u00e7\u00f5es da Knight Therapeutics Inc. s\u00e3o negociadas na TSX sob o s\u00edmbolo GUD. Para mais informa\u00e7\u00f5es sobre a Knight Therapeutics Inc., visite o site da empresa em <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=2229936873&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" rel=\"nofollow noopener\">www.knighttx.com<\/a> ou <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=3601805266&amp;u=http%3A%2F%2Fwww.sedarplus.ca%2F&amp;a=www.sedarplus.ca\" target=\"_blank\" rel=\"nofollow noopener\">www.sedarplus.ca<\/a>.<\/p>\n<p><b>Declara\u00e7\u00f5es prospectivas<\/b><\/p>\n<p>Este documento cont\u00e9m declara\u00e7\u00f5es prospectivas relacionadas \u00e0 Knight Therapeutics Inc. e suas subsidi\u00e1rias. Essas declara\u00e7\u00f5es prospectivas, por sua natureza, envolvem necessariamente riscos e incertezas que podem fazer com que os resultados reais sejam materialmente diferentes daqueles contemplados nessas declara\u00e7\u00f5es. A Knight Therapeutics Inc. considera razo\u00e1veis as premissas nas quais essas declara\u00e7\u00f5es prospectivas se baseiam no momento em que foram preparadas, mas adverte o leitor de que essas premissas sobre eventos futuros, muitos dos quais est\u00e3o al\u00e9m do controle da Knight Therapeutics Inc. e de suas subsidi\u00e1rias, podem acabar sendo incorretas. Fatores e riscos que podem fazer com que os resultados reais sejam materialmente diferentes das expectativas atuais s\u00e3o discutidos no Relat\u00f3rio Anual da Knight Therapeutics Inc. e no Formul\u00e1rio de Informa\u00e7\u00f5es Anuais da Knight Therapeutics Inc. para o ano encerrado em 31 de dezembro de 2023, conforme registrado em <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=3601805266&amp;u=http%3A%2F%2Fwww.sedarplus.ca%2F&amp;a=www.sedarplus.ca\" target=\"_blank\" rel=\"nofollow noopener\">www.sedarplus.ca<\/a>. A Knight Therapeutics Inc. nega qualquer inten\u00e7\u00e3o ou obriga\u00e7\u00e3o de atualizar ou revisar quaisquer declara\u00e7\u00f5es prospectivas devido a novas informa\u00e7\u00f5es ou eventos futuros, exceto se exigido por lei.<\/p>\n<p><b>INFORMA\u00c7\u00d5ES DE CONTATO<\/b><\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\"><b>Contato de investidores:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Knight Therapeutics Inc.<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Samira Sakhia<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Arvind Utchanah<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Presidente e Diretora Executiva<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Diretor Financeiro<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Tel.: 514.484.4483 <\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Tel.: 598.2626.2344 <\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">F: 5144814116<\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">E-mail:\u00a0<\/span><span class=\"prnews_span\"><a href=\"mailto:IR@knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">E-mail:\u00a0<\/span><span class=\"prnews_span\"><a href=\"mailto:IR@knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">IR@knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Website:\u00a0<\/span><span class=\"prnews_span\"><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=2229936873&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">Website:\u00a0<\/span><span class=\"prnews_span\"><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=2229936873&amp;u=https%3A%2F%2Fknighttx.com%2F&amp;a=www.knighttx.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow noopener\">www.knighttx.com<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Logo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=pt&amp;o=4126794-1&amp;h=3821628101&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2373870%2Flogos_todos.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2373870%2Flogos_todos.jpg\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/mma.prnewswire.com\/media\/2373870\/logos_todos.jpg<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\"><img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PT72961&amp;sd=2024-03-28\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/br\/comunicados-para-a-imprensa\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-302102886.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/br\/comunicados-para-a-imprensa\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-302102886.html<\/a><\/p>\n<p>FONTE  Knight Therapeutics Inc.<\/p>\n<\/div>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PT72961&amp;Transmission_Id=202403281259PR_NEWS_LATAM____PT72961&amp;DateId=20240328\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n<p>A <b>OESP<\/b> n\u00e3o \u00e9(s\u00e3o) respons\u00e1vel(is) por erros, incorre\u00e7\u00f5es, atrasos ou quaisquer decis\u00f5es tomadas por seus clientes com base nos Conte\u00fados ora disponibilizados, bem como tais Conte\u00fados n\u00e3o representam a opini\u00e3o da <b>OESP<\/b> e s\u00e3o de inteira responsabilidade da <b>PR Newswire Ltda<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"A Knight Therapeutics Inc. (TSX: GUD) (A &#8220;Knight&#8221; ou &#8220;a Empresa&#8221;) tem o prazer de anunciar que ser\u00e1 reconhecida na quinta lista anual da revista The Globe and Mail&#8217;s 2024 Report o","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[29],"tags":[],"class_list":["post-91544","post","type-post","status-publish","format-standard","hentry","category-prnewseconomia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"og:description\" content=\"A Knight Therapeutics Inc. (TSX: GUD) (A &quot;Knight&quot; ou &quot;a Empresa&quot;) tem o prazer de anunciar que ser\u00e1 reconhecida na quinta lista anual da revista The Globe and Mail&#039;s 2024 Report o\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Ag\u00eancia de Comunica\u00e7\u00e3o\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-28T17:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\" \/>\n<meta name=\"author\" content=\"patric_oliveira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"patric_oliveira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/\"},\"author\":{\"name\":\"patric_oliveira\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"headline\":\"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos\",\"datePublished\":\"2024-03-28T17:13:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/\"},\"wordCount\":1018,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2373870\\\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\",\"articleSection\":[\"PR Newswire Economia\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/\",\"name\":\"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2373870\\\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\",\"datePublished\":\"2024-03-28T17:13:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2373870\\\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2373870\\\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/prnewswire\\\/prnewseconomia\\\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#website\",\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\",\"name\":\"Ag\u00eancia de Comunica\u00e7\u00e3o\",\"description\":\"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/#\\\/schema\\\/person\\\/3565da46092a837cdffa42904dfc6d37\",\"name\":\"patric_oliveira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g\",\"caption\":\"patric_oliveira\"},\"sameAs\":[\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/\"],\"url\":\"https:\\\/\\\/bluestudio.estadao.com.br\\\/agencia-de-comunicacao\\\/author\\\/patric_oliveira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/","og_locale":"pt_BR","og_type":"article","og_title":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o","og_description":"A Knight Therapeutics Inc. (TSX: GUD) (A \"Knight\" ou \"a Empresa\") tem o prazer de anunciar que ser\u00e1 reconhecida na quinta lista anual da revista The Globe and Mail's 2024 Report o","og_url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/","og_site_name":"Ag\u00eancia de Comunica\u00e7\u00e3o","article_published_time":"2024-03-28T17:13:00+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg","type":"","width":"","height":""}],"author":"patric_oliveira","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"patric_oliveira","Est. tempo de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#article","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/"},"author":{"name":"patric_oliveira","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"headline":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos","datePublished":"2024-03-28T17:13:00+00:00","mainEntityOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/"},"wordCount":1018,"commentCount":0,"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg","articleSection":["PR Newswire Economia"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/","name":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos - Ag\u00eancia de Comunica\u00e7\u00e3o","isPartOf":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#primaryimage"},"image":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg","datePublished":"2024-03-28T17:13:00+00:00","author":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37"},"breadcrumb":{"@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2373870\/Knight_Therapeutics_A_Knight_Therapeutics_Inc__se_classifica_na.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/prnewswire\/prnewseconomia\/a-knight-therapeutics-inc-se-classifica-na-quinta-edicao-do-ranking-anual-de-referencial-women-lead-here-da-the-globe-and-mail-sobre-diversidade-de-genero-entre-os-executivos-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"},{"@type":"ListItem","position":2,"name":"A Knight Therapeutics Inc. se classifica na quinta edi\u00e7\u00e3o do ranking anual de referencial Women Lead Here da The Globe and Mail sobre diversidade de g\u00eanero entre os executivos"}]},{"@type":"WebSite","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#website","url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/","name":"Ag\u00eancia de Comunica\u00e7\u00e3o","description":"Conte\u00fado estrat\u00e9gico para engajar seu p\u00fablico com a expertise do Estad\u00e3o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/#\/schema\/person\/3565da46092a837cdffa42904dfc6d37","name":"patric_oliveira","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ca7e6312c4efc0dd6566e6d38573727fdf4333d14aff8583ce79423883088a1?s=96&d=mm&r=g","caption":"patric_oliveira"},"sameAs":["https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/"],"url":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/author\/patric_oliveira\/"}]}},"_links":{"self":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/91544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/comments?post=91544"}],"version-history":[{"count":0,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/posts\/91544\/revisions"}],"wp:attachment":[{"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/media?parent=91544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/categories?post=91544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluestudio.estadao.com.br\/agencia-de-comunicacao\/wp-json\/wp\/v2\/tags?post=91544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}